IBX 0.00% 2.5¢ imagion biosystems limited

Ann: 2021 Annual Report to Shareholders, page-124

  1. 229 Posts.
    lightbulb Created with Sketch. 108
    Ibx needs a new chair and ceo to reinstate confidence.

    tech - obviously works
    regulatory - fda are supportive
    management - market not supporting

    Ibx board needs to appoint seasoned leader with clinical trial experience. One that has a proven record. Then we will see market support.

    Bob had his chance and has failed.
 
watchlist Created with Sketch. Add IBX (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.